Editions:  Austria · Denmark · France · Germany · Italy · Norway · Spain · Sweden · Switzerland
Advertisement

Unused swine flu vaccine goes up in smoke

Share this article

Unused swine flu vaccine goes up in smoke
Photo: DPA
10:12 CET+01:00
Around €250 million worth of swine flu vaccine was due to go up in smoke on Tuesday – as Germany disposed of 16 million doses that people refused to take during last year's outbreak of the potentially deadly virus.

The Pandemrix vaccine was bought up by German state health authorities under orders to make sure they had enough vaccine to cover a third of the population, as the swine flu spread, eventually killing 252 people in Germany.

Yet it soon emerged that only one dose was needed to provoke the desired physical response in patients rather than two as initially thought – and the authorities managed to strike a deal with producer GlaxoSmithKline to get them out of the original deal.

But the flu was much milder than expected, and this, combined with safety fears over the new vaccine, led to only around seven percent of Germans opting to get the vaccine.

Attempts to sell the remaining stocks to other countries largely failed, leaving health authorities sitting on millions of doses of unwanted vaccine – hanging onto them in case they could prove useful before their use-by date. The Frankfurter Allgemeine Zeitung estimated this summer that what remained was worth €250 million.

That date has now passed and trucks loaded with the vaccine were expected at an incineration plant in Magdeburg, Saxony Anhalt, on Tuesday morning.

DAPD/The Local/hc

Get notified about breaking news on The Local

Share this article

Become a Member or sign-in to leave a comment.
Advertisement

From our sponsors

Learn French in Switzerland: A fully immersive experience

Hiking in the Swiss Alps, visiting local chocolate factories, wine-tastings, jazz festivals and car shows are not part of your typical language course. Unless, that is, it's an Alpadia language course.

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

Popular articles

Advertisement
Advertisement